Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02272998
Brief Title: Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT.

First Submitted : October 21, 2014
First Submitted that Met QC Criteria : October 21, 2014
First Posted : October 23, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : February 14, 2020
Last Update Posted : February 17, 2020